Experimental studies on the prevention and treatment of chickenpox and herpes zoster with measles vaccine.
In 151 chickenpox patients treated with live attenuated measles vaccine, the cure rate was 100%. In 145 cases of herpes zoster, the effective rate was 100% (completely cured in 91.7% and improved in 8.3%). In the treated group, the time needed for the subsidence of fever and skin rash and the duration of the disease were markedly shorter than those in the control group (P less than 0.01). It is particularly effective for alleviating pain, preventing and relieving postherpetic neuralgia in patients with zoster. The application of measles vaccine to the patients in the chickenpox incubation period might prevent the development of the disease, and decrease the incidence and death rate of varicella zoster virus infection in highly susceptible patients. The mechanism of its anti-viral action and production of interferon in the body is discussed.
Li
W H
WH
Ming
Z L
ZL
Chen
Q
Q
Li
Y
Y
D002644:Chickenpox / Q000628:therapy*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006562:Herpes Zoster / Q000150:complications / Q000628:therapy*; D006801:Humans; D007223:Infant; D008297:Male; D008458:Measles Vaccine / Q000627:therapeutic use*; D009437:Neuralgia / Q000209:etiology / Q000517:prevention & control; D014613:Vaccines, Attenuated / Q000627:therapeutic use*
D008458:Measles Vaccine; D014613:Vaccines, Attenuated